Deferoxamine inhibits microglial activation, attenuates blood-brain barrier disruption, rescues dendritic damage, and improves spatial memory in a mouse model of microhemorrhages
Deferoxamine inhibits microglial activation, attenuates blood-brain barrier disruption, rescues dendritic damage, and improves spatial memory in a mouse model of microhemorrhages
复制标题
去铁胺抑制小胶质细胞激活,减轻血脑屏障破坏,挽救树突损伤,并改善微出血小鼠模型的空间记忆
DOI:
10.1111/jnc.13657
复制
发表时间:
2016-08-01
影响因子:
4.7
通讯作者:
Pei, Zhong
中科院分区:
文献类型:
--
作者:
He, Xiao-fei;Lan, Yue;Pei, Zhong
Cerebral microbleeds are strongly linked to cognitive dysfunction in the elderly. Iron accumulation plays an important role in the pathogenesis of intracranial hemorrhage. Deferoxamine (DFX), a metal chelator, removes iron overload and protects against brain damage in intracranial hemorrhage. In this study, the protective effects of DFX against microhemorrhage were examined in mice. C57BL6 and Thy-1 green fluorescent protein transgenic mice were subjected to perforating artery microhemorrhages on the right posterior parietal cortex using two-photon laser irradiation. DFX (100mg/kg) was administered 6h after microhemorrhage induction, followed by every 12h for three consecutive days. The water maze task was conducted 7days after induction of microhemorrhages, followed by measurement of blood-brain barrier permeability, iron deposition, microglial activation, and dendritic damage. Laser-induced multiple microbleeds in the right parietal cortex clearly led to spatial memory disruption, iron deposits, microglial activation, and dendritic damage, which were significantly attenuated by DFX, supporting the targeting of iron overload as a therapeutic option and the significant potential of DFX in microhemorrhage treatment.